Table of Contents
Volume 5 | Issue 1
Publication Date: June 2006- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
16-17 |
The Emotional Burden of Low-Risk Prostate Cancer: Proposal for a Change in Nomenclature Oliver Sartor, D. Lynn Loriaux |
|
Meeting Highlights | ||
18-22 |
Highlights from: The 42nd Annual Meeting of the American Society of Clinical Oncology; Atlanta, GA; June 2-6, 2006 G. Kesava Reddy, Preeta Tyagi, Oliver Sartor, Ronald M. Bukowski |
|
Research in Brief | ||
23-25 |
Phase III Study of Sunitinib Malate (SU11248) Versus Interferon-α as First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma Kesava Reddy, Ronald M. Bukowski |
|
Comprehensive Reviews | ||
26-33 |
Current Status and Advances in Nephron-Sparing Surgery Amr Fergany |
|
34-42 |
Systemic Chemotherapy for Urothelial Cancer Guru Sonpavde, Thomas E. Hutson, William R. Berry |
|
43-49 |
Evolving Role of Surgery, Radiation, Hormone Therapy, and Chemotherapy in High-Risk Locally Advanced Prostate Cancer Heather D. Mannuel, Arif Hussain |
|
Original Contributions | ||
50-56 |
Adjuvant Subcutaneous Interleukin-2 in Patients with Resected Renal Cell Carcinoma: A Pilot Study Navneet S. Majhail, Laura Wood, Paul Elson, James Finke, Thomas Olencki, Ronald M. Bukowski |
|
57-60 |
A Phase II Study of Depsipeptide in Refractory Metastatic Renal Cell Cancer Walter M. Stadler, Kim Margolin, Sandy Ferber, William McCulloch, John A. Thompson |
|
61-66 |
Development of an Integrated Prostate Cancer Research Information System William K. Oh, Julia Hayes, Carolyn Evan, Judith Manola, Daniel J. George, Helen Waldron, Meaghan Donovan, John Varner, John Orechia, Beth Katcher, Diana Lu, Arthur Nevins, Renée L. Wright, Lauren Tormey, James Talcott, Mark A. Rubin, Massimo Loda, William R. Sellers, Jerome P. Richie, Philip W. Kantoff, Jane Weeks |
|
Translational Medicine | ||
67-77 |
Molecular Biology of Bladder Cancer: Prognostic and Clinical Implications Anirban P. Mitra, Henry Lin, Ram H. Datar, Richard J. Cote |
|
Case Reports | ||
78-81 |
Clinical Activity of Sorafenib and Sunitinib in Renal Cell Carcinoma Refractory to Previous Vascular Endothelial Growth Factor–Targeted Therapy: Two Case Reports Philip E. Shaheen, Brian I. Rini, Ronald M. Bukowski |
|
82-84 |
Pure Primary Neuroendocrine Tumor of the Prostate: A Rare Entity Sabeur Ketata, Hafedh Ketata, Hamadi Fakhfakh, Ahmad Sahnoun, Ali Bahloul, Tahia Boudawara, Mohamed Nabil Mhiri |
|
85-88 |
Prostate Adenocarcinoma and Human Immunodeficiency Virus: Report of Three Cases and Review of the Literature John K. O’Connor, Lucien A. Nedzi, Ellen L. Zakris |
|
Current Trial | ||
89-92 |
A Phase I Feasibility Study of an Intraprostatic Prostate-Specific Antigen–Based Vaccine in Patients with Prostate Cancer with Local Failure After Radiation Therapy or Clinical Progression on Androgen-Deprivation Therapy in the Absence of Local Definitive Therapy Jean-Baptiste Lattouf, Philip M. Arlen, Peter A. Pinto, James L. Gulley |
|
Clinical Trials | ||
93 |
Selected Clinical Trials in Renal Cell Carcinoma CIG Media Group |
|